[go: up one dir, main page]

LV5504A3 - Saturation of piperazinylalkyl-3 (2H) -pyridazinones or their pharmaceutically acceptable islands - Google Patents

Saturation of piperazinylalkyl-3 (2H) -pyridazinones or their pharmaceutically acceptable islands

Info

Publication number
LV5504A3
LV5504A3 LV931286A LV931286A LV5504A3 LV 5504 A3 LV5504 A3 LV 5504A3 LV 931286 A LV931286 A LV 931286A LV 931286 A LV931286 A LV 931286A LV 5504 A3 LV5504 A3 LV 5504A3
Authority
LV
Latvia
Prior art keywords
piperazinylalkyl
pyridazinones
islands
saturation
pharmaceutically acceptable
Prior art date
Application number
LV931286A
Other languages
Latvian (lv)
Inventor
Heinz Blaschke
Heimo Stroibnig
Harald Fellier
Rita Enzenhofer
Original Assignee
Hafslund Nycomed Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SU894742661A external-priority patent/RU1823874C/en
Application filed by Hafslund Nycomed Pharma filed Critical Hafslund Nycomed Pharma
Publication of LV5504A3 publication Critical patent/LV5504A3/en

Links

LV931286A 1988-12-06 1993-11-30 Saturation of piperazinylalkyl-3 (2H) -pyridazinones or their pharmaceutically acceptable islands LV5504A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT299188 1988-12-06
SU894742661A RU1823874C (en) 1988-12-06 1989-12-05 Method of synthesis of piperazinylalkyl-3(2h)-pyridazinones or their pharmaceutically acceptable salts

Publications (1)

Publication Number Publication Date
LV5504A3 true LV5504A3 (en) 1994-03-10

Family

ID=25599409

Family Applications (1)

Application Number Title Priority Date Filing Date
LV931286A LV5504A3 (en) 1988-12-06 1993-11-30 Saturation of piperazinylalkyl-3 (2H) -pyridazinones or their pharmaceutically acceptable islands

Country Status (1)

Country Link
LV (1) LV5504A3 (en)

Similar Documents

Publication Publication Date Title
FI943377A (en) Preparation of hydrogen peroxide
ATA53492A (en) USE OF CICLOSPORIN FOR PULMONAL ADMINISTRATION
LV10612A (en) Saturation of 1-benzyl-3-oxy-methylindazole or its islands and pharmaceutically acceptable basic substances
IT1231473B (en) COMPOSITION OF SUPEROXIDE DISMUTASIS
DK141090A (en) PREPARATION OF HUMAN PROUROKINASE
LV5504A3 (en) Saturation of piperazinylalkyl-3 (2H) -pyridazinones or their pharmaceutically acceptable islands
DK41585D0 (en) EXPRESSION OF HUMAN ALFA-1-ANTITRYPSIN IN GAER
LV5499A3 (en) Adaptation of 2-thienyloxyethyl derivatives or their pharmaceutically acceptable islands
LV5528A3 (en) Saturation of L-Alanyl-1-Proline derivatives or their pharmaceutical islands
IT8847653A0 (en) SIZZANTE INCLUDING 5 - PHARMACEUTICAL HYDROSCOMPOSITION OF ANOREXYTRPOPHANE
LV5226A3 (en) Saturation of phenylalkylamine or its pharmacologically acceptable form
LV5702A3 (en) Saturation of 5-Chloro-3-chlorosulfonyl-2-thiophenecarbonyl esters
KR910018297U (en) Structure of the escalator to the chin rest
LV5252A3 (en) Saturation of quinolink carbohydrates or their pharmacologically acceptable bonds
KR900002236U (en) Structure of Yianggi's graveyard
KR900004740U (en) Part of
KR910012634U (en) Combined structure of VTR's daily table
BR8903829A (en) PURIFICATION OF PREPARED TELOMMERS OF CHLORINE-TRI-FLUOR-ETHYLENE AND TRI-CHLORINE-TRI-FLUOR-ETHANE
FR2630294B1 (en) VARIETY OF SANGUINOLENTA GODFRA HYPOESTES
KR890700854A (en) How to pattern resist
LV5497A3 (en) Satisfaction of the acquisition of amidines or their pharmaceutically acceptable islands
LV10457A (en) Saturation of cephalosporin amintiazole derivatives and their potassium and sodium islands
KR900005509U (en) Head structure of V-LC
DK171688D0 (en) USE OF INCOME DERIVATIVES
KR910004046U (en) Skeleton of phage-shaped bonpo toys